Contract HHSO100201300011C
Glaxosmithkline, Llc · Department Of Health And Human Services · September 26, 2022
Glaxosmithkline, Llc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 26, 2022 for $14.83 million of work in research and development in biotechnology. It was awarded under full and open competition. The contract has been modified 3 times since the base award It uses cost sharing contract pricing. The most recent modification was on September 2, 2025. If all options are exercised, the contract could reach $218.53 million.
Contract details
- PIID
- HHSO100201300011C
- Award type
- —
- Pricing
- Cost Sharing
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- Health R&D Services; Health Care Services; Experimental Development
- First action
- September 26, 2022
- Latest action
- September 2, 2025
Description
THE PURPOSE OF THIS AGREEMENT MODIFICATION IS TO INCREASE FUNDING FOR CLIN 0004 OPTION 3, REVISE ATTACHMENT 1 SOW, ATTACHMENT 2 - REPORTING REQUIREMENTS, AND REVISE ARTICLE V: AGREEMENT ADMINISTRATION.
Modification timeline
-
September 2, 2025Mod P00039 · Other Administrative Action$218.53M
-
September 10, 2024Mod P00037 · Other Administrative ActionTHE PURPOSE OF THIS AGREEMENT MODIFICATION IS TO OBLIGATE FUNDING TO CLIN 0004 OPTION 3, REVISE ATTACHMENT 2 REPORTING REQUIREMENTS, AND EXTEND THE PERIOD OF PERFORMANCE FOR CLIN 0004 OPTION 3.$215.85M
-
July 9, 2024Mod P00036 · Funding Only ActionTHE PURPOSE OF THIS AGREEMENT MODIFICATION IS TO DE-OBLIGATE $1,612,785.51 IN CANCELLING FUNDING.$202.05M
-
September 26, 2022Mod P00032 · Supplemental Agreement For Work Within ScopeOPTION 3 BUDGET INCREASE OF $9,000,000.00$188.66M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| University Of Illinois | Department Of Health And Human Services | March 26, 2026 | $2.27M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 25, 2026 | $9.65M |
| University Of Texas Medical Branch At Galveston | Department Of Health And Human Services | March 23, 2026 | $1.61M |
| Regeneron Pharmaceuticals Inc | Department Of Health And Human Services | March 19, 2026 | $8.60M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.22M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.23M |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSO100201300011C?
Contract HHSO100201300011C is a federal contract awarded to Glaxosmithkline, Llc by Department Of Health And Human Services on September 26, 2022 for $14.83 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 3 times since the base award.
Who won contract HHSO100201300011C?
Glaxosmithkline, Llc won contract HHSO100201300011C from Department Of Health And Human Services.
How much is contract HHSO100201300011C worth?
Contract HHSO100201300011C has obligated $14.83 million to date, with a total potential value of $218.53 million if all options are exercised.